trisequens has been researched along with cholecalciferol in 1 studies
| Studies (trisequens) | Trials (trisequens) | Recent Studies (post-2010) (trisequens) | Studies (cholecalciferol) | Trials (cholecalciferol) | Recent Studies (post-2010) (cholecalciferol) |
|---|---|---|---|---|---|
| 56 | 35 | 1 | 8,234 | 1,425 | 3,471 |
| Protein | Taxonomy | trisequens (IC50) | cholecalciferol (IC50) |
|---|---|---|---|
| Vitamin D3 receptor | Homo sapiens (human) | 0.087 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, GF; McNair, P; Myrup, B | 1 |
1 trial(s) available for trisequens and cholecalciferol
| Article | Year |
|---|---|
Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment.
Topics: Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholecalciferol; Cholesterol; Cholesterol, HDL; Denmark; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Risk Factors; Time Factors | 1992 |